E-LIB Suche - Ergebnisse für: Rezaï, Keyvan

1

A first-in-class Wiskott-Aldrich syndrome protein activator..:

Spriano, Filippo ; Sartori, Giulio ; Sgrignani, Jacopo...
Haematologica. , 2024

2

Application of an Environmental Monitoring to Assess the Pr..:

Acramel, Alexandre ; Fouque, Julien ; Blondeel-Gomes, Sandy...
Annals of Work Exposures and Health. 66 (2022) 9 - p. 1215-1223 , 2022

Link: https://doi.org/10.1093/..

3

Single radio UHPLC analysis for the quality control of tech..:

Schmitt, Camille ; Fouque, Julien ; Huguet, Samuel...
Applied Radiation and Isotopes. 176 (2021) - p. 109874 , 2021

Link: https://doi.org/10.1016/..

4

Development of potent dual PDK1/AurA kinase inhibitors for ..:

Sestito, Simona ; Bacci, Andrea ; Chiarugi, Sara...
European Journal of Medicinal Chemistry. 226 (2021) - p. 113895 , 2021

Link: https://doi.org/10.1016/..

5

Phase I trial of copanlisib, a selective PI3K inhibitor, in..:

Marret, Grégoire ; Isambert, Nicolas ; Rezai, Keyvan...
Investigational New Drugs. 39 (2021) 6 - p. 1641-1648 , 2021

Link: https://doi.org/10.1007/..

6

TAKTIC: A prospective, multicentre, uncontrolled, phase IB/..:

Vicier, Cecile ; Sfumato, Patrick ; Isambert, Nicolas...
European Journal of Cancer. 159 (2021) - p. 205-214 , 2021

Link: https://doi.org/10.1016/..

7

Ultra‐fast liquid chromatography method coupled with ultrav..:

Fouque, Julien ; Rusu, Timofei ; Huguet, Samuel...
Journal of Labelled Compounds and Radiopharmaceuticals. 64 (2021) 11 - p. 440-446 , 2021

Link: https://doi.org/10.1002/..

8

Targeting Adrenomedullin in Oncology: A Feasible Strategy W..:

Vázquez, Ramiro ; Riveiro, Maria E. ; Berenguer-Daizé, Caroline...
Frontiers in Oncology. 10 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

9

A phase II randomised study of preoperative trastuzumab alo..:

Campone, Mario ; Bachelot, Thomas ; Treilleux, Isabelle...
European Journal of Cancer. 158 (2021) - p. 169-180 , 2021

Link: https://doi.org/10.1016/..

10

Input of serum haptoglobin fucosylation profile in the diag..:

Peta, Valentina ; Zhu, Jianhui ; Lubman, David M....
Clinics and Research in Hepatology and Gastroenterology. 44 (2020) 5 - p. 681-691 , 2020

Link: https://doi.org/10.1016/..

11

Cyclophosphamide dose adjustment based on body weight and a..:

Baudry, E. ; Huguet, S. ; Couderc, A. L....
Cancer Chemotherapy and Pharmacology. 83 (2019) 4 - p. 775-785 , 2019

Link: https://doi.org/10.1007/..

12

Phase I study of onapristone, a type I antiprogestin, in fe..:

Cottu, Paul H. ; Bonneterre, Jacques ; Varga, Andrea...
PLOS ONE. 13 (2018) 10 - p. e0204973 , 2018

Link: https://doi.org/10.1371/..

13

BET bromodomain inhibitor birabresib in mantle cell lymphom..:

Tarantelli, Chiara ; Bernasconi, Elena ; Gaudio, Eugenio...
ESMO Open. 3 (2018) 6 - p. e000387 , 2018

Link: https://doi.org/10.1136/..

14

Permeability and Release of Decontaminating Agent Used in C..:

Gérard, Camille ; Huguet, Samuel ; Escalup, Laurence...
Pharmaceutical Technology in Hospital Pharmacy. 2 (2017) 1 - p. , 2017

Link: https://doi.org/10.1515/..

15

PIKHER2: A phase IB study evaluating buparlisib in combinat..:

Guerin, Mathilde ; Rezai, Keyvan ; Isambert, Nicolas...
European Journal of Cancer. 86 (2017) - p. 28-36 , 2017

Link: https://doi.org/10.1016/..